Oncology (Gastric, Pancreatic, Colorectal, NSCLC) case study - our approach and recruitment method
AGI cancers, including colorectal cancer (CRC), gastric cancer (GC) and pancreatic cancer / pancreatic ductal adenocarcinoma (PDAC), represent poor survival rates with current therapies. This was a new opportunity for the Client.
NSCLC - products are established, and there was a need of greater background understanding.
Email [email protected] or use our contact us form below for bids, questions or further information.